155 related articles for article (PubMed ID: 9881083)
1. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
Sakamoto M; Mikasa K; Hamada K; Konishi M; Maeda K; Yoshimoto E; Ueda K; Majima T; Sawaki M; Kita E; Narita N
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2259-66. PubMed ID: 9881083
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant drugs increase natural killer cell activity in lung cancer.
Bobek V; Boubelik M; Fiserová A; L'uptovcová M; Vannucci L; Kacprzak G; Kolodzej J; Majewski AM; Hoffman RM
Lung Cancer; 2005 Feb; 47(2):215-23. PubMed ID: 15639720
[TBL] [Abstract][Full Text] [Related]
3. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
7. A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer.
Ishikawa A; Motohashi S; Ishikawa E; Fuchida H; Higashino K; Otsuji M; Iizasa T; Nakayama T; Taniguchi M; Fujisawa T
Clin Cancer Res; 2005 Mar; 11(5):1910-7. PubMed ID: 15756017
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer.
Hamada K; Mikasa K; Yunou Y; Kurioka T; Majima T; Narita N; Kita E
Chemotherapy; 2000; 46(1):49-61. PubMed ID: 10601798
[TBL] [Abstract][Full Text] [Related]
9. Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer.
Neninger Vinageras E; de la Torre A; Osorio Rodríguez M; Catalá Ferrer M; Bravo I; Mendoza del Pino M; Abreu Abreu D; Acosta Brooks S; Rives R; del Castillo Carrillo C; González Dueñas M; Viada C; García Verdecia B; Crombet Ramos T; González Marinello G; Lage Dávila A
J Clin Oncol; 2008 Mar; 26(9):1452-8. PubMed ID: 18349395
[TBL] [Abstract][Full Text] [Related]
10. [The quality of life after chemotherapy in advanced non-small cell lung cancer patients].
Słowik-Gabryelska A; Szczepanik A; Kalicka A
Pol Merkur Lekarski; 1999 Jan; 6(31):18-22. PubMed ID: 10344148
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-12-mediated killer activity in lung cancer patients.
Haku T; Yanagawa H; Nabioullin R; Takeuchi E; Sone S
Cytokine; 1997 Nov; 9(11):846-52. PubMed ID: 9367545
[TBL] [Abstract][Full Text] [Related]
13. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer.
Nemunaitis J; Dillman RO; Schwarzenberger PO; Senzer N; Cunningham C; Cutler J; Tong A; Kumar P; Pappen B; Hamilton C; DeVol E; Maples PB; Liu L; Chamberlin T; Shawler DL; Fakhrai H
J Clin Oncol; 2006 Oct; 24(29):4721-30. PubMed ID: 16966690
[TBL] [Abstract][Full Text] [Related]
15. Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.
Vollmer RT; Govindan R; Graziano SL; Gamble G; Garst J; Kelley MJ; Christenson RH
Clin Cancer Res; 2003 May; 9(5):1728-33. PubMed ID: 12738727
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells].
Chen J; Cao X; Xiu Q
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964
[TBL] [Abstract][Full Text] [Related]
17. Effect of clarythromycin on the distant metastases of human lung cancer cells in SCID mice.
Parajuli P; Yano S; Hanibuchi M; Nokihara H; Shinohara T; Sone S
J Med Invest; 1998 Feb; 44(3-4):205-10. PubMed ID: 9597810
[TBL] [Abstract][Full Text] [Related]
18. [Administration of clarithromycin (CAM) to non-small cell lung cancer].
Majima T; Mikasa K; Sakamoto M; Hamada K; Konishi M; Maeda K; Yoshimoto E; Murakawa K; Takahashi K; Kita E; Narita N
Jpn J Antibiot; 2000 Jan; 53 Suppl A():52-5. PubMed ID: 10756452
[No Abstract] [Full Text] [Related]
19. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
[TBL] [Abstract][Full Text] [Related]
20. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]